How to guide the selection of patients for trimodality therapy: The case for tumor immune and stromal signature

Luca Boeri, R. Jeffrey Karnes, Emanuele Montanari

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	S329-S331
Journal	Translational Andrology and Urology
Volume	8
DOIs	https://doi.org/10.21037/tau.2019.05.10
State	Published - 2019

ASJC Scopus subject areas

@article{531dad7b394a48d0a9d1f27904eb1094,

title = "How to guide the selection of patients for trimodality therapy: The case for tumor immune and stromal signature",

author = "Luca Boeri and {Jeffrey Karnes}, R. and Emanuele Montanari",

year = "2019",

doi = "10.21037/tau.2019.05.10",

language = "English (US)",

volume = "8",

pages = "S329--S331",

journal = "Translational Andrology and Urology",

issn = "2223-4683",

publisher = "AME Publishing Company",

}

TY - JOUR

T1 - How to guide the selection of patients for trimodality therapy

T2 - The case for tumor immune and stromal signature

AU - Boeri, Luca

AU - Jeffrey Karnes, R.

AU - Montanari, Emanuele

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85072102434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072102434&partnerID=8YFLogxK

U2 - 10.21037/tau.2019.05.10

DO - 10.21037/tau.2019.05.10

M3 - Review article

AN - SCOPUS:85072102434

SN - 2223-4683

VL - 8

SP - S329-S331

JO - Translational Andrology and Urology

JF - Translational Andrology and Urology

ER -